Learn more about Ginkgo Biosecurity and other organizations in the field!
The July edition of our Biosecurity newsletter is out, featuring two new organizations, IBBIS and Sentinel Bio, and many more! Tessa Alexanian
Skip to main content
Learn more about Ginkgo Biosecurity and other organizations in the field!
The July edition of our Biosecurity newsletter is out, featuring two new organizations, IBBIS and Sentinel Bio, and many more! Tessa Alexanian
To view or add a comment, sign in
The September issue of Nugenis News is live on our website. You can read it by clicking on the link below. https://lnkd.in/eSsKybBp #financialplanning #newsletter
To view or add a comment, sign in
Highly experienced Financial Planner working with HNW private clients to help them achieve their goals.
After a well earned Summer break we're back with the latest edition of our newsletter, including a look at funding care in later life and the usual investment and market review. Details below, or at https://lnkd.in/eBNTsmYj where you can also find all of the previous editions too. #financialplanning #investments #carefeefunding #newsletter
The September issue of Nugenis News is live on our website. You can read it by clicking on the link below. https://lnkd.in/eSsKybBp #financialplanning #newsletter
To view or add a comment, sign in
Assistant Professor of Pediatrics, at Harvard Medical School / Data Management and Analysis Core Lead, Precision Vaccines Program, Boston Children's Hospital
LongCOVID: Our study from the IMPACC cohort explores patient-reported recovery data for COVID-19 and tracks outcomes from acute infection to one year post-hospital discharge. We identified factors and immune profiles from the acute phase linked to impaired clinical and functional recovery during the subsequent year. #covid19 #longcovid #scicomm
The IMPACC study led by Drs. Al Ozonoff, Nadine Rouphael, Patrice Becker, IMPACC group and many US institutions published in Nature Communications on post-acute sequelae of SARS-CoV-2 (PASC) results. https://ow.ly/MRMo50QnRXw
To view or add a comment, sign in
It was really nice taking a speech at the "Plant Biological Network - 2023 Symposium" on state of play of BioControlAgents in EU, trends and perspectives. I discussed on the Commission's initiatives already completed and on those ongoing to facilitate access to market of #biopesticides (e.g., #microorganisms, pheromones and others) to make EU #agriculture more #sustainable!!! For more information on our activities concerning micro-organisms used in plant protection: https://lnkd.in/eMB3Vz4S #EUFoodSafety #eufarm2fork #biological #farmtofork #farm2fork #foodsafety #plantprotection #organicfarming #europeancommission #eu #eugreendeal #farming #organic #ipm #integratedpestmanagement #greendeal #sustainableuse
We are proud to present the annual Plant Biologicals Network Symposium program! You can find the symposium program here: https://lnkd.in/dzEDPQMU Registration for the PBN symposium closes on 8 November. You can register for the symposium here: https://lnkd.in/ebE5JSbb
To view or add a comment, sign in
#Webinar4EarlyBirds If you want to start a day with a fresh #KnowledgeBoost between 8-9 AM EST on Mar 6, this is for you! If you are in Euro zone, then an afternoon cup of coffee goes with this, too! Registration link below. #InterestingTopic #BioTekCytation #Knowledge4Breakfast
Join us as our guest speaker Claudius Witzler introduces his workflow of identifying the molecular basis of thrombo-inflammatory processes in our live webinar. Find out more and to register: https://bit.ly/3OFQ91l
To view or add a comment, sign in
It’s no secret that federal labs are always at risk of defunding, which puts our nation’s health, security and technological advances at risk. This is where CO-LABS comes into the picture. One of our roles is to facilitate symbiotic relationships between federal labs and institutions. Through engagements with stakeholders spanning academia, the private sector, and civic leadership, we help facilitate the potential for new partnerships, technology transfer, and job creation. To continue our work, we are asking for your support on the upcoming Colorado Gives Day on Tuesday, December 5, 2023. Raymond P. Goodrich, Executive Director of Infectious Disease Research Center at Colorado State University (recently retired) had this to say about our organization, "The work that CO-LABS does helps us maintain a leadership position that not only benefits Colorado, but also provides the source of problem-solving and problem preventing efforts ranging from infectious disease research, agricultural programs, energy programs, defense-related programs and environmental efforts that impact the citizens of Colorado, the United States and the world in general.” Your support serves not only as an endorsement but as an investment in the scientific ecosystem, fostering resilience and perpetuating the invaluable contributions of federal labs to societal progress. Engage with us to fortify the foundation of scientific discovery—support CO-LABS with your commitment to advancing knowledge and innovation. Your support makes a tangible difference in advancing our mission - see more at Colorado Gives Day: https://lnkd.in/em5mTAYK
To view or add a comment, sign in
Save the date for this upcoming webinar on fibrin formation and fibrinolysis testing in research!
🚨New Webinar Alert🚨Join our June webinar on fibrin formation and fibrinolysis testing and research: https://lnkd.in/g4z55Wsh
To view or add a comment, sign in
Paul Wallace will be attending the World ADC Event Series in London. Catch him to learn about the use of non-canonical building blocks for precise conjugation, which is ideal for ADCs, various protein conjugates, and clicking pharmacological enhancers onto proteins. Discover how modular formats can revolutionize the discovery and development of biologics - and also what's the best way to access out platform and expertise. Non-canonical building blocks are fascinating, and their programmable incorporation can revolutionize what we can do with biologics. In the case of Constructive Bio, this approach allows for unprecedented fidelity, specificity, and scalability!
Our CBO Paul Wallace is attending the 14th Annual World ADC London 2024, part of the World ADC Event Series on March 12-14. With our ability to recode biology and produce programmable biomolecules in E. coli and CHO we can optimize ADCs by: - Fine-tuning drug-antibody ratio (DAR) and payload location - Incorporating dual payloads - Improving the therapeutic index, stability and PK. Keen to learn more? Get in touch via email to [email protected] to arrange an introduction. We look forward to seeing you there!
To view or add a comment, sign in
If I had a penny for every-time someone asked "So, you're producing recombinant proteins in fruit flies, huh? How on earth does that work?" I would have a lot of money 😝 Well, wonder no more! Get ready for an exclusive behind-the-scenes look into our game-changing platform. Curious about how we're revolutionizing biomanufacturing with those tiny winged assistants? Secure your spot for an upcoming webinar featuring our CEO, Matt, spilling the beans on our innovative platform! Got some technical queries itching for answers? We've got you covered with live responses! But wait, there's more! We're on the lookout for trailblazers keen on elevating their protein game. Flexible batch sizes for complex proteins for preclinical applications? That's our specialty. Dive into collaboration with us and take your proteins to new heights! 😉
📢 WEBINAR ALERT! 📢 Join us on December 6 at 11 AM MST! Our co-founder and CEO, Matt Anderson-Baron, will walk us through a technical deep dive on how our biomanufacturing platform could make your difficult-to-express protein at scale. Register here 👉 https://bit.ly/47ggNVR
To view or add a comment, sign in